BPC157 and TB500 are not broadly FDAapproved for general injury recovery or antiaging, and many uses are considered offlabel or experimental, so therapy should only be pursued within applicable regulations
GLP-1 agonists are generally well tolerated with GI side effects such as nausea, vomiting, and diarrhea predominating
A more strategic clinical decision is to maintain the GLP-1 at a tolerable maintenance dose to control appetite, and introduce a complementary mechanism
Final Thoughts Both oral and injectable BPC-157 are exceptional tools in regenerative medicine, offering overlapping yet distinct benefits
Enhanced Cellular Repair: Growth hormone plays a crucial role in cellular regeneration, promoting healthier skin, stronger bones, and overall vitality